Sat.Mar 09, 2024

article thumbnail

#ScienceSaturday: March 9, 2024

KIF1A

#ScienceSaturday posts share exciting scientific developments and educational resources with the KAND community. Each week, Dr. Dylan Verden of KIF1A.ORG summarizes newly published KIF1A-related research and highlights progress in rare disease research and therapeutic development. Meet our Guest Bloggers! This spring we’ve been quite fortunate to be joined by 6 Master’s students from Columbia University, who have been contributing to our creation of community resources as part of the

article thumbnail

How to Deal With Endometriosis Pain

Drugs.com

SATURDAY, March 9, 2024 -- Endometriosis causes crippling pain in women, with some spending up to a month of every year debilitated by it.“We’re talking about pain that’s beyond ‘I took two ibuprofen and went to work,’” said Dr. Kristin.

105
105
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Drug Patent Expirations for the Week of March 10, 2024

Drug Patent Watch

NASCOBAL (cyanocobalamin) Endo pharms inc Patent: 7,404,489 Expiration: Mar 12, 2024 See More … For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com… The post Drug Patent Expirations for the Week of March 10, 2024 appeared first on DrugPatentWatch - Make Better Decisions.

Drugs 69
article thumbnail

Test Driven Development with Databricks

Perficient: Drug Development

I don’t like testing Databricks notebooks and that’s a problem. I like Databricks. I like Test Driven Development. Not in an evangelical; 100% code coverage or fail kind of way. I just find that a reasonable amount of code coverage gives me a reasonable amount of confidence. Databricks has documentation for unit testing. I tried to test one notebook using another notebook.

article thumbnail

How Machine Learning Drives Clinical Trial Efficiency

Clinical trial data management is increasingly challenging as studies grow in complexity. Quickly accessing and analyzing study data is vital for assessing trial progress and patient safety. In this paper, we explore real-time data access and analysis for proactive study management. We investigate using adverse event (AE) data to monitor safety and discuss a clinical analytics platform that supports collaboration and data review workflows.

article thumbnail

Deciphering the tip of migrating neurons: Discovery of growth cone in migrating neurons involved in promoting neuronal migration and regeneration in the brain after injury

SCIENMAG: Medicine & Health

The structure and functions of the tip of migrating neurons remain elusive.

article thumbnail

Test Driven Development with Databricks (1 of 2)

Perficient: Drug Development

I don’t like testing Databricks notebooks and that’s a problem. I like Databricks. I like Test Driven Development. Not in an evangelical; 100% code coverage or fail kind of way. I just find that a reasonable amount of code coverage gives me a reasonable amount of confidence. Databricks has documentation for unit testing. I tried to test one notebook using another notebook.